Nanosonics (ASX:NAN) Margin of Safety % (DCF FCF Based): N/A (As of Jun. 26, 2026)


ASX:NAN Nanosonics Ltd ASX:NAN
83 GF Score
Price A$3.22
GF Value A$4.49
Valuation Modestly Undervalued
! 1 Warning Sign
View Full Analysis

What is Nanosonics Margin of Safety % (DCF FCF Based)?

Margin of Safety % (DCF FCF Based) = (Intrinsic Value: DCF (FCF Based) - Current Price) / Intrinsic Value: DCF (FCF Based).

Note: Discounted FCF model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

Nanosonics's Predictability Rank is 1-Star. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF FCF Based) is not calculated.

ASX:NAN vs ISRG, BDX, MDLN: Margin of Safety % (DCF FCF Based) Comparison

For the Medical Instruments & Supplies subindustry, Nanosonics's Margin of Safety % (DCF FCF Based), along with its competitors' market caps and Margin of Safety % (DCF FCF Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Nanosonics Margin of Safety % (DCF FCF Based) vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Nanosonics's Margin of Safety % (DCF FCF Based) distribution charts can be found below:

* The bar in red indicates where Nanosonics's Margin of Safety % (DCF FCF Based) falls into.


ASX:NAN
83GF Score
Nanosonics Ltd ASX:NAN
Margin of Safety % (DCF FCF Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Nanosonics (ASX:NAN) Overvalued in 2026?

Based on GuruFocus' analysis, Nanosonics stock appears to be undervalued. The current stock price of A$3.22 is trading 28.3% below its estimated GF Value™ of A$4.49. GuruFocus considers Nanosonics to be Modestly Undervalued.

Key valuation signals for ASX:NAN:

  • Margin of Safety % (DCF FCF Based): N/A
  • GF Value™: A$4.49 vs. price of A$3.22 (28.3% below fair value)
  • GF Score™: 83/100 with 1 warning sign

No single metric tells the full story. See the ASX:NAN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Nanosonics Business Description

Other Exchanges NNCSF:USA
Address 7-11 Talavera Road, Level 1 Building A, Macquarie Park, Sydney, NSW, AUS, 2113
Nanosonics is largely a single-product firm, and its Trophon device provides high-level disinfection of ultrasound probes used in semicritical procedures. The patented technology uses low-temperature sonically activated hydrogen peroxide mist suitable for probes sensitive to damage. Automated HLD is increasingly being used as the standard of care globally as it is superior in preventing cross-infection of patients. Nanosonics' revenue consists of capital sales of Trophon units, ongoing consumables sales, and service revenue. By December 2025, there were 38,000 Trophon units installed globally. Market penetration rates range from over 75% in Australia and New Zealand, over 50% in the US to single-digit penetration in Europe, Middle East, and Africa, and elsewhere in the Asia-Pacific region.
83GF Score

Get the complete analysis for ASX:NAN

Margin of Safety % (DCF FCF Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$3.22
Price
A$4.49
GF Value